These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 12919407)

  • 1. Diversity and significance of Burkholderia species occupying diverse ecological niches.
    Coenye T; Vandamme P
    Environ Microbiol; 2003 Sep; 5(9):719-29. PubMed ID: 12919407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diversity of the Burkholderia cepacia complex and implications for risk assessment of biological control strains.
    Parke JL; Gurian-Sherman D
    Annu Rev Phytopathol; 2001; 39():225-58. PubMed ID: 11701865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infection with Burkholderia cepacia complex genomovars in patients with cystic fibrosis: virulent transmissible strains of genomovar III can replace Burkholderia multivorans.
    Mahenthiralingam E; Vandamme P; Campbell ME; Henry DA; Gravelle AM; Wong LT; Davidson AG; Wilcox PG; Nakielna B; Speert DP
    Clin Infect Dis; 2001 Nov; 33(9):1469-75. PubMed ID: 11588691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Agricultural use of Burkholderia (Pseudomonas) cepacia: a threat to human health?
    Holmes A; Govan J; Goldstein R
    Emerg Infect Dis; 1998; 4(2):221-7. PubMed ID: 9621192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Burkholderia cepacia: medical, taxonomic and ecological issues.
    Govan JR; Hughes JE; Vandamme P
    J Med Microbiol; 1996 Dec; 45(6):395-407. PubMed ID: 8958242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The various lifestyles of the Burkholderia cepacia complex species: a tribute to adaptation.
    Vial L; Chapalain A; Groleau MC; Déziel E
    Environ Microbiol; 2011 Jan; 13(1):1-12. PubMed ID: 20880095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nosocomial Acquisition of Burkholderia gladioli in patients with cystic fibrosis.
    Clode FE; Metherell LA; Pitt TL
    Am J Respir Crit Care Med; 1999 Jul; 160(1):374-5. PubMed ID: 10390428
    [No Abstract]   [Full Text] [Related]  

  • 8. Updated version of the Burkholderia cepacia complex experimental strain panel.
    Coenye T; Vandamme P; LiPuma JJ; Govan JR; Mahenthiralingam E
    J Clin Microbiol; 2003 Jun; 41(6):2797-8. PubMed ID: 12791937
    [No Abstract]   [Full Text] [Related]  

  • 9. Genomovar diversity amongst Burkholderia cepacia complex isolates from an Australian adult cystic fibrosis unit.
    Kidd TJ; Bell SC; Coulter C
    Eur J Clin Microbiol Infect Dis; 2003 Jul; 22(7):434-7. PubMed ID: 12884074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Burkholderia cepacia: current clinical issues, environmental controversies and ethical dilemmas.
    Jones AM; Dodd ME; Webb AK
    Eur Respir J; 2001 Feb; 17(2):295-301. PubMed ID: 11334134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infections by Burkholderia spp.: the psychodramatic life of an opportunistic pathogen.
    Valvano MA
    Future Microbiol; 2006 Aug; 1(2):145-9. PubMed ID: 17661657
    [No Abstract]   [Full Text] [Related]  

  • 12. Burkholderia cepacia genomovar VI, a new member of the Burkholderia cepacia complex isolated from cystic fibrosis patients.
    Coenye T; LiPuma JJ; Henry D; Hoste B; Vandemeulebroecke K; Gillis M; Speert DP; Vandamme P
    Int J Syst Evol Microbiol; 2001 Mar; 51(Pt 2):271-9. PubMed ID: 11321071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular characterization of Burkholderia cepacia isolates from cystic fibrosis (CF) patients in an Italian CF center.
    Petrucca A; Cipriani P; Valenti P; Santapaola D; Cimmino C; Scoarughi GL; Santino I; Stefani S; Sessa R; Nicoletti M
    Res Microbiol; 2003 Sep; 154(7):491-8. PubMed ID: 14499935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic methods for determining genomovar status of the Burkholderia cepacia complex.
    Henry DA; Mahenthiralingam E; Vandamme P; Coenye T; Speert DP
    J Clin Microbiol; 2001 Mar; 39(3):1073-8. PubMed ID: 11230429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exopolysaccharide production by mucoid and non-mucoid strains of Burkholderia cepacia.
    Cérantola S; Bounéry J; Segonds C; Marty N; Montrozier H
    FEMS Microbiol Lett; 2000 Apr; 185(2):243-6. PubMed ID: 10754255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Burkholderia cepacia complex infection in Italian patients with cystic fibrosis: prevalence, epidemiology, and genomovar status.
    Agodi A; Mahenthiralingam E; Barchitta M; Gianninò V; Sciacca A; Stefani S
    J Clin Microbiol; 2001 Aug; 39(8):2891-6. PubMed ID: 11474009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Burkholderia cepacia complex: a contraindication to lung transplantation in cystic fibrosis?
    LiPuma JJ
    Transpl Infect Dis; 2001 Sep; 3(3):149-60. PubMed ID: 11493397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insights into the role of extracellular polysaccharides in Burkholderia adaptation to different environments.
    Ferreira AS; Silva IN; Oliveira VH; Cunha R; Moreira LM
    Front Cell Infect Microbiol; 2011; 1():16. PubMed ID: 22919582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Burkholderia (Pseudomonas) cepacia epidemiology in a cystic fibrosis population: a genome finger-printing study.
    Cazzola G; Amalfitano G; Tonolli E; Perazzoli C; Piacentini I; Mastella G
    Acta Paediatr; 1996 May; 85(5):554-7. PubMed ID: 8827098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diversity and occurrence of Burkholderia spp. in the natural environment.
    Compant S; Nowak J; Coenye T; Clément C; Ait Barka E
    FEMS Microbiol Rev; 2008 Jul; 32(4):607-26. PubMed ID: 18422616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.